Profile data is unavailable for this security.
About the company
Ascletis Pharma Inc is a China-based investment holding company principally engaged in the research, development, production, marketing and sales of pharmaceutical products. The Company mainly focuses on viral diseases, non-alcoholic steatohepatitis (NASH) and oncology fields. Viral diseases pipeline includes Ritonavir, Ravidasvir, Danoprevir and others. NASH pipeline includes ASC40, ASC41, ASC42 and others. Oncology pipeline includes ASC60, ASC61 and others.
- Revenue in HKD (TTM)61.03m
- Net income in HKD-156.06m
- Incorporated2014
- Employees219.00
- LocationAscletis Pharma Inc12F, Building D198 Qidi Road, HIPARKHANGZHOU ChinaCHN
- Websitehttps://www.ascletis.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fusen Pharmaceutical Co Ltd | 609.95m | -39.12m | 899.95m | 1.15k | -- | 1.48 | -- | 1.48 | -0.0524 | -0.0524 | 0.811 | 0.8103 | 0.4199 | 1.95 | 8.36 | 531,314.50 | -2.69 | 0.9678 | -5.54 | 1.74 | 52.95 | 51.95 | -6.42 | 2.59 | 0.6096 | 0.756 | 0.3797 | 27.95 | 15.02 | 4.13 | -4.83 | -- | 0.2124 | -- |
| Brii Biosciences Ltd | 665.37k | -188.53m | 926.86m | 128.00 | -- | 0.2754 | -- | 1,393.00 | -0.2592 | -0.2592 | 0.0009 | 4.61 | 0.0002 | -- | -- | 5,198.20 | -5.60 | -- | -5.84 | -- | -- | -- | -29,881.69 | -- | -- | -- | 0.001 | -- | -98.80 | -- | 63.90 | -- | -- | -- |
| JW (Cayman) Therapeutics Co Ltd | 187.49m | -828.20m | 936.93m | 398.00 | -- | 0.5133 | -- | 5.00 | -2.01 | -2.01 | 0.4556 | 4.40 | 0.0704 | 1.68 | 65.54 | 471,069.10 | -31.11 | -39.77 | -35.21 | -44.00 | 50.74 | -- | -441.74 | -1,316.81 | 3.86 | -47.82 | 0.1592 | -- | 19.32 | -- | 9.23 | -- | -19.87 | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.21bn | 175.54m | 941.32m | 2.64k | 5.26 | 0.8325 | 3.27 | 0.4258 | 0.2073 | 0.2073 | 2.61 | 1.31 | 1.12 | 2.53 | 10.54 | 836,363.10 | 8.95 | 7.69 | 14.15 | 11.75 | 59.73 | 60.44 | 8.01 | 6.73 | 0.894 | -- | 0.1424 | 42.46 | 12.26 | 12.41 | 53.00 | 13.86 | 17.65 | 3.22 |
| Hbm Holdings Ltd | 698.94m | 178.03m | 1.15bn | 177.00 | 6.19 | 1.18 | 5.39 | 1.65 | 0.2422 | 0.2422 | 0.9523 | 1.28 | 0.3886 | 3.90 | 3.01 | 3,948,808.00 | 9.88 | -54.61 | 14.13 | -66.04 | 97.73 | 97.81 | 25.43 | -400.28 | 3.28 | 6.98 | 0.3556 | -- | 120.13 | 127.06 | 116.61 | -- | -12.62 | -- |
| Jacobson Pharma Corporation Ltd | 1.68bn | 212.16m | 1.18bn | 1.59k | 5.30 | 0.4947 | 2.98 | 0.7012 | 0.1112 | 0.1409 | 0.8822 | 1.19 | 0.3722 | 2.87 | 7.50 | 940,829.50 | 5.16 | 4.91 | 6.61 | 6.60 | 42.05 | 41.81 | 13.85 | 14.32 | 1.01 | 5.62 | 0.3646 | 35.97 | 11.91 | 2.89 | 41.30 | 4.42 | -6.22 | 6.39 |
| Ascletis Pharma Inc | 61.03m | -156.06m | 1.28bn | 219.00 | -- | 0.5202 | -- | 20.91 | -0.1467 | -0.1467 | 0.0568 | 2.42 | 0.022 | 2.30 | 3.86 | 278,688.90 | -5.62 | -6.43 | -5.91 | -6.64 | 45.92 | 35.67 | -255.70 | -243.38 | 16.54 | -6.09 | 0.0036 | -- | 4.63 | -19.39 | 54.04 | -- | -20.44 | -- |
| VIVA Biotech Holdings | 2.32bn | -125.22m | 1.36bn | 2.08k | -- | 0.3393 | 11.33 | 0.5858 | -0.0637 | -0.0637 | 1.20 | 1.86 | 0.2805 | 4.84 | 5.21 | 1,119,194.00 | -1.30 | -1.39 | -1.79 | -1.68 | 34.26 | 34.81 | -4.63 | -5.44 | 1.15 | 1.00 | 0.3412 | -- | -9.42 | 59.31 | 78.03 | -- | 31.98 | -- |
| Mabpharm Ltd | 93.99m | -225.77m | 1.42bn | 347.00 | -- | 6.43 | -- | 15.14 | -0.0548 | -0.0548 | 0.0228 | 0.0536 | 0.0893 | 0.1176 | 6.02 | 270,876.10 | -21.44 | -21.42 | -28.92 | -27.49 | 86.32 | -- | -240.19 | -486.40 | 0.7596 | -19.03 | 0.5591 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
| Essex Bio-Technology Ltd | 1.71bn | 275.26m | 1.42bn | 1.48k | 5.35 | 0.7405 | 4.26 | 0.8347 | 0.4689 | 0.4689 | 2.87 | 3.39 | 0.6161 | 2.28 | 3.35 | 1,152,300.00 | 9.94 | 11.20 | 13.21 | 14.73 | 90.20 | 86.01 | 16.13 | 19.77 | 1.46 | -- | 0.1326 | 16.16 | 29.51 | 7.72 | 22.11 | 3.56 | 7.29 | 7.39 |
| Wuhan YZY Biopharma Co Ltd | -100.00bn | -100.00bn | 1.44bn | 123.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -1.50 | -- | -- | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 68.50m | -387.27m | 1.50bn | 301.00 | -- | 1.30 | -- | 21.96 | -0.501 | -0.501 | 0.0886 | 1.46 | 0.0419 | -- | 5.21 | 227,573.70 | -23.66 | -45.76 | -26.86 | -49.30 | 5.04 | -- | -565.36 | -372.22 | -- | -- | 0.1636 | -- | -33.66 | -- | 3.43 | -- | 19.18 | -- |
| TOT Biopharm International Co Ltd | 841.83m | -40.72m | 1.52bn | 551.00 | -- | 2.06 | 289.76 | 1.81 | -0.0562 | -0.0562 | 1.16 | 0.9582 | 0.5808 | 1.87 | 8.03 | 1,527,816.00 | -2.81 | -20.01 | -3.72 | -25.21 | 73.53 | 74.74 | -4.84 | -68.53 | 1.48 | -4.60 | 0.3348 | -- | 76.54 | 81.88 | 24.36 | -- | 21.04 | -- |
| Immunotech Biopharm Ltd | 0.00 | -361.07m | 1.57bn | 211.00 | -- | 8.41 | -- | -- | -0.7017 | -0.7017 | 0.00 | 0.3638 | 0.00 | -- | -- | 0.00 | -38.88 | -37.42 | -50.88 | -45.48 | -- | -- | -- | -- | 1.03 | -2.51 | 0.4327 | -- | -- | -- | -5.25 | -- | -8.46 | -- |
| Cryofocus Medtech Shanghai Co Ltd | 44.16m | -105.13m | 1.63bn | 392.00 | -- | 9.34 | -- | 36.82 | -0.4397 | -0.4397 | 0.1847 | 0.7282 | -- | -- | -- | 112,653.80 | -- | -- | -- | -- | 75.83 | -- | -258.23 | -- | 4.08 | -- | 0.0597 | -- | 50.83 | -- | 13.13 | -- | -- | -- |
| Hua Medicine | 82.62m | -227.79m | 1.65bn | 177.00 | -- | 14.02 | -- | 19.93 | -0.233 | -0.233 | 0.0846 | 0.1113 | 0.0538 | 1.69 | 13.03 | 466,756.30 | -14.84 | -25.61 | -17.56 | -28.81 | 48.78 | -- | -275.73 | -1,654.70 | 6.06 | -- | 0.6238 | -- | 335.31 | -- | -3.80 | -- | 14.07 | -- |
Data as of May 27 2024. Currency figures normalised to Ascletis Pharma Inc's reporting currency: Hong Kong Dollar HKD
1.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 7.89m | 0.78% |
| Dimensional Fund Advisors LPas of 31 Jan 2024 | 3.58m | 0.35% |
| JPMorgan Asset Management (China) Co Ltd.as of 31 Dec 2023 | 2.75m | 0.27% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.82m | 0.18% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 1.73m | 0.17% |
| Fullgoal Asset Management (HK) Ltd.as of 30 Jun 2023 | 924.00k | 0.09% |
| Dimensional Fund Advisors Ltd.as of 31 Mar 2024 | 328.38k | 0.03% |
| SSgA Funds Management, Inc.as of 09 May 2024 | 200.00k | 0.02% |
| American Century Investment Management, Inc.as of 09 May 2024 | 186.00k | 0.02% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 45.00k | 0.00% |
More ▼
Data from 30 Jun 2023 - 23 May 2024Source: FactSet Research Systems Inc.
